{"result": "(\"entity\"<|>ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Endocrine Society is a professional organization that provides clinical practice guidelines for the management of endocrine disorders, including primary aldosteronism.)\n##\n(\"entity\"<|>PRIMARY ALDOSTERONISM<|>EVENT<|>Primary aldosteronism is a condition characterized by excessive production of aldosterone, leading to hypertension and other health issues.)\n##\n(\"entity\"<|>J CLIN ENDOCRINOL METAB<|>ORGANIZATION<|>The Journal of Clinical Endocrinology and Metabolism is a scientific journal that publishes research and guidelines related to endocrinology.)\n##\n(\"entity\"<|>YOUNG WF, JR<|>PERSON<|>Young WF, Jr. is a medical professional known for his contributions to the diagnosis and treatment of primary aldosteronism.)\n##\n(\"entity\"<|>WALTHAM<|>GEO<|>Waltham is a city in Massachusetts, USA, where UpToDate Inc. is located, providing medical information and guidelines.)\n##\n(\"entity\"<|>UPTODATE INC<|>ORGANIZATION<|>UpToDate Inc. is a clinical decision support resource that provides evidence-based information for healthcare professionals.)\n##\n(\"entity\"<|>PHILADELPHIA<|>GEO<|>Philadelphia is a city in Pennsylvania, USA, where the Williams Textbook of Endocrinology is published.)\n##\n(\"entity\"<|>ELSEVIER<|>ORGANIZATION<|>Elsevier is a publishing company known for producing scientific literature, including medical textbooks and journals.)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>PRIMARY ALDOSTERONISM<|>The Endocrine Society provides clinical practice guidelines for the management of primary aldosteronism<|>8)\n##\n(\"relationship\"<|>YOUNG WF, JR<|>PRIMARY ALDOSTERONISM<|>Young WF, Jr. is a key figure in the diagnosis and treatment of primary aldosteronism<|>7)\n##\n(\"relationship\"<|>UPTODATE INC<|>PRIMARY ALDOSTERONISM<|>UpToDate Inc. provides information and guidelines related to the diagnosis of primary aldosteronism<|>6)\n##\n(\"relationship\"<|>J CLIN ENDOCRINOL METAB<|>PRIMARY ALDOSTERONISM<|>The Journal of Clinical Endocrinology and Metabolism publishes research and guidelines on primary aldosteronism<|>7)\n##\n(\"relationship\"<|>ELSEVIER<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Elsevier publishes the Williams Textbook of Endocrinology, which includes information on primary aldosteronism<|>5)\n##\n(\"relationship\"<|>WALTHAM<|>UPTODATE INC<|>Waltham is the location of UpToDate Inc., which provides clinical guidelines<|>4)\n##\n(\"relationship\"<|>PHILADELPHIA<|>ELSEVIER<|>Philadelphia is the city where Elsevier publishes various medical textbooks, including those on endocrinology<|>4)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection,\n                                                                                                                                               diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889-916.\n         C. El hiperaldosteronismo familiar de tipo 1 es una enfermedad leve que no conlleva                                                 • Lahera Vargas M. Hiperaldosteronismo primario. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es\n             un riesgo aumentado de morbimortalidad prematura.                                                                                 (última modificación: 25 de noviembre de 2015).\n                                                                                                                                             • Young WF, Jr. Diagnosis of primary aldosteronism. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature\n         D.  En el hiperaldosteronismo familiar de tipo 1 hay un intercambio de material genético                                              review current through: Apr. 2019.\n             entre los genes CYP11B2 y CYP11Bl, que da lugar a un gen quimérico.                                                             • Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n                                                                                                                                               of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.\n\n\n\n276                                                                                                                                                                                                                                                                             277\n---\n                                                                                                                                                                                                                          SUPRARRENALES                                        5\n\n\n\n     23  En el abordaje inicial de un paciente con sospecha de hiperaldosteronismo                                                           24  Respecto al tratamiento quirúrgico del adenoma productor de aldosterona:\n         primario es cierto que:                                                                                                                 A. La exéresis laparoscópica selectiva del adenoma es la intervención de elección.\n         A. El cociente aldosterona plasmática actividad de renina plasmática (ALD/ARP) es una                                                   B. La hipopotasemia espontánea postoperatoria se produce en prácticamente todos los\n             prueba de cribado obsoleta.                                                                                                             pacientes que consiguen la resolución de la hipertensión.\n         B. La concentración plasmática de aldosterona basal carece de utilidad.                                                                 C. La aldosterona plasmática suele tardar 7-10 días en normalizarse tras la cirugía.\n         C. El cociente ALD/renina plasmática (medida directa) no ha demostrado mayor sensibilidad                                               D.  La resolución de la hipertensión durante al menos los 5 años siguientes a la cirugía\n             ni especificidad que el cociente ALD ARP para el diagnóstico.                                                                           ocurre en el 50% de los pacientes.\n         D.  Un cociente ALD (ng/dl)/ARP (ng/ml/h) > 30 permite obviar las pruebas de confirmación.\n                                                                                                                                                 COMENTARIO\n         COMENTARIO                                                                                                                              Se recomienda la adrenalectomía unilateral laparoscópica para los pacientes con hipe-\n         La prueba de cribado recomendada para el estudio del paciente con sospecha de hipe-                                                     raldosteronismo primario por enfermedad unilateral documentada (adenoma productor de\n         raldosteronismo primario es la relación entre la aldosterona plasmática y la actividad de                                               aldosterona o       hiperplasia suprarrenal unilateral).\n         renina plasmática (ALD/ARP). El valor de corte más aceptado para la relación ALD/ARP es                                                 Debería medirse la aldosterona plasmática y la actividad de renina plasmática 1 a 2 días\n         30 cuando la aldosterona se presenta como nanogramos por decilitro (ng/dl) y la actividad                                               después de la cirugía para comprobar la respuesta bioquímica, aunque los niveles de reni-\n         de renina plasmática como nanogramos por mililitro y hora (ng/ml/h).                                                                    na pueden tardar tiempo en corregirse. Deberían suspenderse los suplementos de potasio\n         Una limitación de la relación ALD/ARP es que, en presencia de valores muy bajos de ARP                                                  y la espironolactona el primer día del postoperatorio y reducir el resto del tratamiento\n         (p.  ej., 0,1 ng/ml/h), la relación ALD/ARP puede ser superior a 30, aunque los valores de                                              antihipertensivo en función de la respuesta.\n         aldosterona sean bajos y no sugerentes de hiperaldosteronismo                              (p. ej., 4 ng/dl).                           Se debe recomendar una dieta rica en sodio para evitar la hiperpotasemia que puede apa-\n         La ARP se calcula incubando el plasma y determinando la cantidad de angiotensina I que se                                               recer por el hipoaldosteronismo secundario a la supresión crónica de la glándula contrala-\n         genera a partir del angiotensinógeno plasmático, que sirve como sustrato, por unidad de tiem-                                           teral. Hasta un 5% de los pacientes pueden necesitar tratamiento con mineralocorticoides\n         po, de ahí que su resultado se exprese como ng/ml\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}